Selected article for: "acute phase and disease course"
Author: Christine Dahlke; Jasmin Heidepriem; Robin Kobbe; Rene Santer; Till Koch; Anahita Fathi; My L. Ly; Stefan Schmiedel; Peter H. Seeberger; Marylyn M. Addo; Felix F. Loeffler
Title: Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
  • Document date: 2020_4_17
    • ID: icl1t9d6_26
    Snippet: Patients with mild symptoms displayed a much stronger IgA response, soon after onset of symptoms (patient #2 d3, patient #4 d4) that decreased during the course of disease 7 -14 days later. The IgG response has a similar, but much less pronounced trend and appears more persistent. The number of reactive IgG peptides appears lower in the early acute phase in comparison to IgA......
    Document: Patients with mild symptoms displayed a much stronger IgA response, soon after onset of symptoms (patient #2 d3, patient #4 d4) that decreased during the course of disease 7 -14 days later. The IgG response has a similar, but much less pronounced trend and appears more persistent. The number of reactive IgG peptides appears lower in the early acute phase in comparison to IgA.

    Search related documents:
    Co phrase search for related documents
    • acute phase and iga response: 1, 2, 3
    • acute phase and IgG peptide: 1
    • acute phase and IgG response: 1, 2, 3, 4, 5, 6, 7, 8
    • acute phase and mild symptom: 1, 2, 3
    • acute phase and patient symptom: 1
    • acute phase and patient symptom onset: 1
    • acute phase and persistent appear: 1
    • iga response and IgG peptide: 1
    • iga response and IgG response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • iga response and mild symptom: 1
    • iga response and strong iga response: 1, 2, 3, 4, 5, 6
    • IgG peptide and reactive IgG peptide: 1
    • IgG peptide and strong iga response: 1
    • IgG response and mild symptom: 1
    • IgG response and patient symptom: 1
    • IgG response and patient symptom onset: 1
    • IgG response and persistent appear: 1
    • IgG response and strong iga response: 1
    • low appear and persistent appear: 1